Carlyle and Brighton Park Agree to Invest $200 Million in Indegene
Investment will accelerate company’s global expansion and consolidate its industry-leading position in healthtech solutions
01 Growth Equity 2.0
02 About UsBrighton Park Capital aims to invest in companies that provide highly innovative solutions
These companies seek to disrupt and challenge conventional ways of solving problems and provide products and services that deliver significant value add to their customers. Many times these companies are creating new markets and offer the opportunity to leverage technology to create better outcomes, business processes and customer relationships.
03 Our Value Creation
We seek to partner with great management teams and bring purpose built value-add capabilities that match the unique requirements of our companies.
Each company we invest in is different and requires strategic resources from Brighton Park to address specific needs. We aim to help our companies attract world class talent, develop market-leading products, build highly productive sales organizations, and connect better with customers through our extensive set of C-level relationships with large enterprises.
Our Partner group brings over 60 years of experience investing in and working to build great technology companies.
04 Team
05 PortfolioBrighton Park is singularly focused on high growth companies.
We seek to partner with exceptional management teams and use our operating experience to build world class companies. We intend to invest for the long term and prioritize the needs of our portfolio companies. We focus on the growth agenda, including helping our portfolio companies build global businesses.
February 2nd, 2021
Carlyle and Brighton Park Agree to Invest $200 Million in Indegene
Read More
August 10th, 2020
RocketReach Secures Significant Growth Investment From Brighton Park Capital
Read More
May 11th, 2020
Paradox Raises $40M Series B to Help Companies Embrace the Future of Work with Conversational AI
Read More
